Correlation Between Pharvaris and THC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pharvaris and THC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and THC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharvaris BV and THC Therapeutics, you can compare the effects of market volatilities on Pharvaris and THC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of THC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and THC Therapeutics.

Diversification Opportunities for Pharvaris and THC Therapeutics

-0.6

Correlation Coefficient

Pharvaris  THC Therapeutics

Excellent diversification

The 3 months correlation between Pharvaris and THC is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and THC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on THC Therapeutics and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with THC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of THC Therapeutics has no effect on the direction of Pharvaris i.e., Pharvaris and THC Therapeutics go up and down completely randomly.

Pair Corralation between Pharvaris and THC Therapeutics

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the THC Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 32.49 times less risky than THC Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The THC Therapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  0.04  in THC Therapeutics on September 5, 2024 and sell it today you would earn a total of  0.02  from holding THC Therapeutics or generate 50.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pharvaris BV  vs.  THC Therapeutics

Pharvaris BV

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Pharvaris may actually be approaching a critical reversion point that can send shares even higher in January 2025.

THC Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in THC Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, THC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharvaris and THC Therapeutics

The main advantage of trading using opposite Pharvaris and THC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, THC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in THC Therapeutics will offset losses from the drop in THC Therapeutics' long position.

The idea behind Pharvaris BV and THC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.